Dr. Ramaswamy received a $150,000 grant renewal from the Florida Heart Research Foundation. The focus of this renewal is on ensuring that the allogeneic elastin-rich valve replacements that we are producing will have robust structural properties and extended durability to be all tested in vitro before returning to in vivo studies in the latter portion of 2022. Both Ariadna Herrera and Claudia Ponce will be funded as RAs via this renewal.